SCHEMBL2466409

SCHEMBL2466409

COC(=O)c1c2c(c3ccccc3c1C)OC(c1ccccc1)(c1ccccc1N1CCN(c3ccc(OC)cc3)CC1)C=C2

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.41
MAPT P10636 10/20 0.40
KMT2A Q03164 6/20 0.39
MEN1 O00255 4/20 0.39
LMNA P02545 3/20 0.39
POLB P06746 2/20 0.39
TP53 P04637 3/20 0.38
MAPK1 P28482 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
SLC1A2 P43004 1/20 0.36
GAA P10253 3/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
USP2 O75604 1/20 0.35
ALDH1A1 P00352 1/20 0.35
RAB9A P51151 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2467149 0.91 PKM (0.36) PKMMAPTKMT2AMEN1LMNA
SCHEMBL8978512 0.82 ATM (0.41) MAPTKMT2AMEN1LMNATP53
SCHEMBL7608091 0.80 SMN1; SMN2 (0.41) MAPTKMT2AMEN1LMNAMAPK1
SCHEMBL10102254 0.79 ATM (0.39) MAPTKMT2AMEN1TP53L3MBTL1
SCHEMBL17929226 0.78 ATM (0.38) MAPTKMT2AMEN1LMNATP53
SCHEMBL6172997 0.78 PLA2G2A (0.38) KMT2AMEN1LMNAL3MBTL1ALDH1A1
SCHEMBL5160384 0.76 MAPT (0.40) MAPTKMT2AMEN1LMNAPOLB
SCHEMBL3822262 0.76 ALDH1A1 (0.40) MAPTKMT2AMEN1LMNAGAA
SCHEMBL8919915 0.75 MEN1 (0.38) MAPTKMT2AMEN1LMNAPOLB
SCHEMBL12610521 0.75 MAPT (0.34) MAPTKMT2AMEN1LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2370420-B9 PHOTOCHROMIC COMPOUNDS TRANSITIONS OPTICAL INC (US) 2019-11-13 EP disclosed
EP-2370420-B1 PHOTOCHROMIC COMPOUNDS TRANSITIONS OPTICAL INC (US) 2019-05-22 EP disclosed
US-20180291008-A1 Photochromic Compounds TRANSITIONS OPTICAL, INC. 2018-10-11 US disclosed
US-20180291009-A1 Photochromic Compounds TRANSITIONS OPTICAL, INC. 2018-10-11 US disclosed
US-20180291007-A1 Photochromic Compounds TRANSITIONS OPTICAL, INC. 2018-10-11 US disclosed
US-10005763-B2 Photochromic compounds TRANSITIONS OPTICAL, INC. (US) 2018-06-26 US disclosed
US-10000472-B2 Photochromic compounds TRANSITIONS OPTICAL, INC. (US) 2018-06-19 US disclosed
US-20160333262-A1 Photochromic Compounds TRANSITIONS OPTICAL, INC. 2016-11-17 US disclosed
US-20160332995-A1 Photochromic Comounds TRANSITIONS OPTICAL, INC. 2016-11-17 US disclosed
US-9405041-B2 Photochromic compounds TRANSITIONS OPTICAL, INC. (US) 2016-08-02 US disclosed
US-20140154514-A1 PHOTOCHROMIC COMPOUNDS TRANSITIONS OPTICAL, INC. (US) 2014-06-05 US disclosed
US-8705160-B2 Photochromic compounds TRANSITIONS OPTICAL, INC. (US) 2014-04-22 US disclosed
US-20120200907-A1 PHOTOCHROMIC COMPOUNDS TRANSITIONS OPTICAL, INC. (US) 2012-08-09 US disclosed
US-8211338-B2 Photochromic compounds TRANSITIONS OPTICAL, INC (US) 2012-07-03 US disclosed
EP-2370420-A1 PHOTOCHROMIC COMPOUNDS TRANSITIONS OPTICAL, INC. (US) 2011-10-05 EP disclosed
WO-2010065393-A1 PHOTOCHROMIC COMPOUNDS TRANSITIONS OPTICAL, INC. (US) 2010-06-10 WO disclosed
US-20090309076-A1 PHOTOCHROMIC COMPOUNDS TRANSITIONS OPTICAL, INC. (US) 2009-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180291007-A1 Photochromic Compounds CCR4, CCR8, CBR3 PKM 4051/4885MAPT 3431/4885KMT2A 2229/4885
US-20160332995-A1 Photochromic Comounds CCR4, CCR3, CCR8 PKM 4037/4885MAPT 3824/4885KMT2A 3018/4885
US-10005763-B2 Photochromic compounds CCR4, CCR8, CBR3 PKM 4042/4885MAPT 3402/4885KMT2A 2193/4885
US-20180291008-A1 Photochromic Compounds CCR4, CBR3, CCR8 PKM 4029/4885MAPT 3410/4885KMT2A 2077/4885
US-20160333262-A1 Photochromic Compounds CCR4, CCR8, CBR3 PKM 4042/4885MAPT 3402/4885KMT2A 2193/4885
US-20180291009-A1 Photochromic Compounds CCR4, CCR8, CBR3 PKM 4063/4885MAPT 3424/4885KMT2A 2244/4885
US-10000472-B2 Photochromic compounds CCR4, CCR8, CBR3 PKM 4042/4885MAPT 3402/4885KMT2A 2193/4885
US-20120200907-A1 PHOTOCHROMIC COMPOUNDS CCR4, CCR8, CBR3 PKM 4083/4885MAPT 3507/4885KMT2A 2255/4885
US-20090309076-A1 PHOTOCHROMIC COMPOUNDS CCR4, CCR8, CBR3 PKM 4042/4885MAPT 3402/4885KMT2A 2193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.